Ruxolitinib - a Steroid Sparing Agent in Chronic Graft-versus-Host Disease

Inhibition of the Janus-associated kinases (JAK) with ruxolitinib (RUX) reduces graft-versus-host disease (GVHD) in preclinical and clinical models. Nineteen allograft recipients with moderate/severe steroid-dependent chronic GVHD received RUX as ≥ 2nd line salvage. RUX was well tolerated, and led t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Khoury, Hanna Jean, Langston, Amelia A., Kota, Vamsi K., Wilkinson, Jennifer A., Pusic, Iskra, Jillella, Anand, Bauer, Stephanie, Kim, Audrey S, Roberts, Danielle, Al-Kadhimi, Zaid, Bodo, Imre, Winton, Elliott, Arellano, Martha, DiPersio, John F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6041160/
https://ncbi.nlm.nih.gov/pubmed/29367708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-017-0081-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados